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INTRODUCTION
aleurone as a monolayer of cells overlying the endosperm, which is rich in fibre and phenolic compounds. 85
Furthermore, breads can be also rich in soluble fibres, like those made with oat and barley as good sources of 86 β-glucans, which are well known to reduce post-prandial blood glucose and blood cholesterol [13] [14] [15] , risk 87 factors in the development of coronary heart disease (CHD) 16 . 88
Similarly to other cereal-based products, wholemeal bread is generally a good source of phenolic 89 compounds, mainly as esters bound to arabinoxylans 17 , with a minor contribution of soluble free or 90 conjugated compounds 18 . Polyphenols exist as secondary metabolites in several different plants, in which 91 they can act as a defence mechanism against parasites and toxic compounds 19, 20 . Phenolic compounds are 92 widely diffused in all plant foods including fruits, vegetables and beverages (tea and coffee), the 93 consumption of which may lead to a phenolic intake of ~1000 mg per day, in a typical American diet 21 . 94
Bread products contribute to this daily phenolic intake, especially when they include bran. 95
Cereal grains constitute a good source of phenolic acids (PAs), in addition to alkylresorcinols and lignans. 96
PAs can be divided in two groups, hydroxycinnamic and hydroxybenzoic acids, deriving from the 97 hydroxylation of the cinnamic or benzoic acid moiety. Hydroxycinnamic acids are the most abundant PAs 98 and chiefly consist of ferulic acid (FA), p-coumaric acid (CA), caffeic acid, and sinapic acid (SA). 99
Hydroxybenzoic acid derivatives include p-hydroxybenzoic, protocatechuic, vanillic, syringic and gallic 100
acids. 101
Polyphenols are not included in the category of micronutrients, as they are not essential for the maintenance 102 of vital functions. However, several studies indicate that phenolic compounds might be responsible for part 103 of the beneficial effects associated with the consumption of plant-based foods, such as the association 104 between fruit and vegetable intake and reduced CVD risk 22 . In particular, in vitro studies have demonstrated 105 the involvement of polyphenols and their metabolites in several features linked to prevention of 106 inflammation, oxidative stress and many other recognised pathophysiological processes [23] [24] [25] . Furthermore, 107
Study (n= 41,836), in which polyphenol intake was inversely associated with inflammation 27 , and 113 specifically, whole grain polyphenol intake was inversely associated with the incidence of colorectal 114 cancer 28 . 115
Evidence from human intervention trials on the protective effects of phenol-rich foods against many chronic 116 diseases has been inconsistent, possibly because of differences in food composition, as well as differences in 117 the absorption and metabolism of various phenolic compounds. One of the main issues contributing to the 118 inconsistency in results concerns studies attributing the effects to a single compound or a class of foods, 119 because a single compound can be present in several different foods, and a class of foods can contain 120 mixtures of polyphenols. In addition, the in vivo effects of polyphenols are strongly influenced by their 121
bioavailability. 122
Generally, bioavailability is the fraction of an ingested nutrient or compound that reaches the systemic 123 circulation and may be utilized. Thus, it is multifactorial in that it includes gastrointestinal digestion, 124 absorption, metabolism, tissue distribution, and bioactivity of the nutrient/compound. However, due to the 125 difficulty in investigating the bioactivity, bioavailability is commonly considered both the fraction of a 126 compound as well as the metabolite(s) of that compound that reach the systemic circulation 29 . 127
Bioavailability can be affected by a wide range of factors, not only related to the food (e.g. chemical form of 128 the compound, characteristics of the food matrix), but also to the individual (e.g. gastric emptying, intestinal 129 transit time), resulting in high inter-individual variability 24, 30 . 130
Beginning with ingestion and digestion of a food, the food matrix can influence the bioaccessibility of the 131 phenols because the amount that is released from within the matrix will influence the fraction that is made 132 available for intestinal absorption. Effects on bioaccessibility can be evaluated in vitro by simulation of 133 gastric and small intestinal digestion 31 . In vitro methods are quick and inexpensive ways to estimate the 134 bioaccessibility of a bioactive compound, including changes resulting from variations in the food matrix and 135 food processing. However, these methods cannot completely measure of the bioavailability of bioactives, as 136 this requires in vivo methodologies. 137
The present review summarizes potential strategies, including innovative technologies, that can be applied 138 during the bread-making process in an effort to increase the fraction of phenolic compounds reaching thesystemic circulation, and what is currently known about the usefulness of these strategies as assessed in in 140 vitro bioaccessibility and in vivo bioavailability studies. 141
142

POTENTIAL STRATEGIES TO INCREASE PHENOLIC CONTENT IN BREAD PRODUCTS: 143
EFFECTS OF THE BREAD-MAKING PROCESS 144
Various processing techniques are applied to grains in order to transform the raw materials into finished 145 products with good sensory characteristics and nutritional quality. Since technological processes affect the 146 chemical constituents and physical properties of foods, it is expected they also influence the phenolics within 147 grain products, thus impacting the potential beneficial health effects. The effect of various food-processing 148 methods on phenolic compounds has therefore become an important area of research. 149
A review of the literature has highlighted three main strategies that can be applied to design phenolic-150 enriched breads: the first approach focuses on the use of raw materials naturally rich in phenolic compounds; 151 the second focuses on the application of bio-processing techniques on raw materials; and the third focuses on 152 the processing conditions that can be applied during bread-making (Table 1) . 153
Raw materials 154
Whole grains are a good source of phenolic compounds, mostly concentrated in the bran, but levels of 155 phenolics in the final products can vary widely depending on the raw materials and on the pre-processing 156 techniques. In addition to whole wheat, barley, and rye, minor cereals (e.g. sorghum, millets; 32 ), pigmented 157 grains [33] [34] [35] , and ancient grains (e.g. eikorn, emmer 36 and pseudocereals like buckwheat, quinoa and 158 amaranth) 37 represent a good source of phenolics, thus their use in bread products has increased in the 159 marketplace. Since phenolic compounds are present in the external layers of the kernel, adding bran fractions 160 to refined flour is one of the most common trends to enhance phenolic content in bread products. 161 milled flours 38, 39 . More recently, debranning has been demonstrated as an effective strategy to produce bran 168 fractions rich in aleurone particles 40 , which are particularly rich in phenolics, thus recovering the bioactive 169 compounds that are concentrated in the external layers of grain kernels [41] [42] [43] . 170
Regarding to physical treatments, air classification technology is an effective way to separate grain flours 171 into fractions with different sizes, properties, and chemical composition, such as protein, starch, and dietary 172
fibre. When applied to phenolic-rich material, it is a good technique to select fractions with a high content of 173 phenolic compounds 44 . 174
Micronization, also known as ultrafine grinding, is a mechanical treatment, used to change or damage the 175 fibre matrix, causing some phenolics which were linked or embedded into the matrix to be exposed so that 176 the total phenolic content in bran increases 45 , likely due to an increase in extractability. 177 Lastly, biotechnological processes (i.e. germination, fermentation, and enzymatic treatments) have been used 178 to improve the PA content in bran. Germination is the process by which a plant grows from a seed. During 179 germination, high levels of hydrolytic enzymes, such as amylases and proteases, accumulate in the cereal 180 seed, so that the insoluble endosperm starch and protein reserves are hydrolyzed into soluble forms that can 181 be transported to the embryo to meet the needs of the growing plant. A recent review on the effects of grain 182 germination concluded that during this process a net increase in total phenolic content and total antioxidant 183 capacity 46 is observed. It is also thought that germination may increase the extractability of polyphenolic 184 compounds, by releasing bound polyphenols, therefore making them more soluble in extraction solvents. 185
Fermentation is another beneficial pre-processing technique which effectively releases phenolics from the 186 bran of various grains 47, 48 . The enzymes produced by the added microorganisms have the potential to release 187 insoluble bound PAs from bran and thereby improve their bioaccessibility and potential bioavailability 49 . In 188 the case of sourdough fermentation, the effect of the reduction in pH is also important 50 property, baking quality, and shelf-life 54 . 199
Bread-making process 200
In addition to the formulation and pre-processing of bread products, the bread-making process also 201 influences the content and bioavailability of phenolic compounds in the final bread product. 202
Bread-making includes several fundamental operations, namely mixing and kneading, fermentation or 203 leavening, and baking, which are indispensable for producing an attractive end product. During mixing, 204 ingredients are evenly distributed and blended. In wheat breads, interaction with water leads to significant 205 structural changes in proteins, resulting in gluten formation; a three-dimensional network structure resulting 206 in a cohesive, completely homogenous, non-sticky mass with well-defined rheological characteristics. These 207 attractive properties depend on the procedure applied and equipment used, as well as on the presence of 208 components, such as phenolics, that may negatively affect gluten viscoelasticity. For example, phenolic 209 compounds can form complexes with proteins, via hydrogen bonding between the hydroxyl groups of the 210 phenols and the carbonyl group of the peptide residue [55] [56] [57] . 211
Studies have demonstrated that dough mixing causes an overall decrease in total PAs, such as bound FA, SA 212 and CA, in various grains 50, 58, 59 reaching up to 50%. However, free FA has been demonstrated to increase 213 significantly in one study showing up to five times the initial level, suggesting that mixing may also facilitate 214 the release of bound phenolic compounds into free and more bioaccessible forms 35, 58 . 215
Various mechanisms have been proposed to explain the overall decrease in PAs resulting from dough 216 mixing. High-speed mixing breaks protein disulfide bonds and creates thiol free radicals in gluten, which 217 then react with reducing compounds, like PAs, in flour 60 . Considering the proposed effect of mixing on the 218 formation of bonds between phenolics and proteins, a decrease in phenolic content in various reports may be 219 more accurately described as a reduction in their bioaccessibility and thus extractability 61 . 220
Another proposed effect of mixing on phenolics is the hydrolysis of oxidative enzymes such as oxygenase 221 and peroxidase, that are present in flours, which become active when water is added and thus decrease theamount of phenolics like FA 62 .
223
The leavening and fermentation process increases the original volume of the bread and creates a porous 224 structure, through the action of a leavening agent, usually baker's yeast (i.e. Saccharomyces cerevisiae), 225 which converts the fermentable sugars present in the dough into ethanol and CO 2 . 226
The fermentation and leavening process may contribute to an increase in PA bioavailability. Two 227 mechanisms for the fermentation-induced increase in bioaccessibility and bioavailability of phenolic 228 compounds during bread-making have been proposed: i) via the structural breakdown of the cell wall matrix 229
by degrading enzymes present in both grains and microbes activated by the leavening agent 63 ; and ii) via the 230 synthesis or enzymatic transformation of various bioactive compounds 47 . However, studies investigating PA 231 content in fermented dough are not consistent. This inconsistency is likely due to differences in the enzymes 232 produced from yeast or other microorganisms and native enzymes present in various types of grains. As an 233 example, rye has been described to have much more native enzymatic activity compared to wheat 35, 50, 51, 59 . In 234 addition, fermentation conditions, particularly temperature, pH, and duration, are contributing factors to PA Sourdough fermentation has been demonstrated to increase the bioaccessibility of PAs as, for example, 245
Liukkonen et al. (2003) 64 found that this type of fermentation increased the content of methanol-extracted 246 phenolic compounds, in addition to demonstrating an increase in antioxidant capacity 43, 60 
Methods of assessment of bioaccessibility: Static vs. Dynamic Methods 282
Bioaccessibility is the determination of the amount of bioactive compounds potentially absorbable from the 283 gut lumen, and can be measured using different methods which simulate in vivo digestion. Several in vitro 284 methods have been developed to investigate the effect of the food matrix and of different processing 285 techniques on the ability of nutrients or bioactive compounds, like polyphenols, to become available to 286 absorbtion 73 . These methods try to mimic in vivo digestion by simulating the oral, gastric and small intestinal 287 phases and, occasionally, large intestinal fermentation 74 . 288
There are two general categories of methods: static and dynamic (non-static). In static models, products 289 remain largely immobile in a single bioreactor, and the ratios between meal, enzymes, salt, bile acids and all 290 other substrates of the biological digestive reactions are kept constant at each phase of digestion. Static 291 methods can differ in incubation time and characteristics of the digestive juices, namely the concentrations of 292 the enzymes resulting from the preparation, for example by the addition of specific enzymes to inorganic and 293 organic solutions. They can be also adjusted for pH on the basis of the specific gut compartment, as static 294 methods consist of multiple phases, including oral, gastric and intestinal, each of which can vary slightly in 295 different studies. 296
In the oral phase, the incubation time of the test sample can vary between 2 and 30 minutes 74,75 with either: i) 297 human buffered saliva with phosphate or saline solution 74 ; ii) α-amylase solution 75,76 ; or iii) saliva solution 298 prepared with different salts and with the addition of α-amylase, uric acid and mucin 77 . Some studies bypass 299 the oral phase 72,78 possibly because a significant contribution to the digestive process is not expected in this 300 stage due to the short time during which food is in contact with saliva in in vivo conditions 79 . 301
In the gastric phase, a pepsin solution is normally used and incubation time can vary between 1 and 2 302 . Incubation time can vary from 2 to over 24 hours 74, 76, 77 . 307
After gastrointestinal digestion simulation, the point at which bioaccessibility determination of compounds 308 of interest occurs can also vary. One method is to centrifuge or filtrate the sample mixture to measure the 309 bioaccessibility of compounds based on the levels present in the supernatant. An alternative method includes 310 the use of a dialysis membranes, which allows for the discrimination between high and low molecular weight 311 components 31 . When a dialysis tube is used, the undigested material (the fraction remaining inside the tube) 312 can be analysed for the content of the nutrient/bioactive compound under study (e.g. PAs) and then the 313 bioaccessibility can be obtained as a difference from that measured in the sample before digestion 74, 76 . The 314 time at which the dialysis tube is used may vary, as in some works it is used immediately after the gastric 315 phase 74 while in others after the intestinal digestion phase 76 . 316
In general, static methods are quick, cost-effective and can be used to assess effects on several nutrients and 317 bioactive compounds resulting from changes made to the food matrix, by changing the raw materials or 318 processing techniques used, compared to the reference material or to the original food matrix. 319
The main limitations of static methods are that they do not provide the most accurate simulation of the 320 complex dynamic physiological processes occurring during in vivo conditions. This has led to the 321 development of dynamic (non-static) digestion models. A common and very sophisticated gut model to 322 simulate the human digestive system was developed by The Netherland Organization for Applied Scientific 323
Research 80 . Their commercial gastrointestinal model, also known as the TIM system, is a multi-324 compartmental dynamic computer-controlled model that has been successfully used to study the 325 bioaccessibility of many compounds including vitamins and minerals, as well as phenolics 81, 82 . The TIM 326 system simulates the dynamic conditions occurring in the four main gastrointestinal compartments: stomach, 327 duodenum, jejunum and ileum. All parameters, including gastric and small intestinal transit, flow rate, 328 composition of digestive fluids, temperature, pH, and removal of water and metabolites, are all remote-329 computer controlled. In the jejunal and ileal compartments, a dialysis system allows for the removal of 330 digestion products, isolating the dialysate fraction, which contains the bioaccessible products from theOverall, the use of realistic concentrations of digestive enzymes, pH levels, transit times appropriate to each 333 digestion step, and salt concentrations, among other factors, contribute to a more accurate simulation of the 334 gastrointestinal tract. Furthermore, the removal of the products of digestion and the appropriate mixing at 335 each stage of digestion in the use of dynamic methods may represent crucial points in mimicking 336 physiological conditions in vivo. 337
In vitro studies investigating effects of altering raw materials on phenolic bioaccessibility 338 Table 2 shows the main findings of all studies identified in the literature and evaluating the bioaccessibility 339 of phenolic compounds in bread. Among the different potential strategies to apply in the bread-making 340 process to increase the bioaccessibility of phenolic compounds in breads, as summarized in Table 1 , the 341 efficacy of using different raw materials has been the most investigated. In particular, the majority of the 342 studies has explored the bioaccessibility in breads made by using different types of cereals or pseudocereals. 343
As expected, wheat-based breads (both white and wholegrain) were the most investigated (in all 9 studies), 344 with few investigating rye (2/9), oat (1/9) and barley (1/9), either alone or mixed. Among pseudocereals, 345 buckwheat breads were analysed in two out of the nine studies. 346
Almost all studies included wheat bread as an internal control to be compared with breads made with 347 different cereals. Generally, white bread is characterized by a low bioaccessibility of PAs, partially 348 ascribable to the very low FA content in the samples In another study conducted by Angioloni and Collar (2011) 72 , the authors found a 58% bioaccessibility of the 356 total phenolics (measured as Total Phenolic Content, TPC) in the supernatant from static in vitro digestion of 357 wheat bread. This is similar to a second study conducted by the same authors, in which they found ~84% 358
The differences in bioaccessibility in white wheat bread found in the latter two studies (58% and 84% for 361 TPC) compared to the former three studies (0% FA, 4.9% FA and 10.2% FA) may be linked to the former 362 three measuring FA only, using chromatographic methods, while the latter two measured total phenolics 363 using the Folin-Ciocalteau method. In addition to potential differences due to type of in vitro method (i.e. 364 static vs. dynamic), further sources of variability might include the phenolic content in the raw materials, as 365 well as the state of the test samples used for post-digestion measurements (i.e. dialysate samples in former 3 366 versus supernatant and precipitate used in the latter 2 studies). 367
Three studies compared the bioaccessibility of phenolic compounds in white bread with respect to whole 368 wheat bread 69, 75, 83 . As expected, the whole wheat breads had higher initial PA content, due to the 369 preservation of the outer layers of the kernels (e.g. 9-12-fold higher FA content in whole wheat versus white 370 bread). This contributed to a greater net content of bioaccessible PAs, demonstrating how the use of different 371 raw materials is a valid strategy for this purpose. However, although the net content of bioaccessible PAs in 372 whole wheat bread is higher than that of white bread, the bioaccessibility was higher in white breads 373 ). Nevertheless, other studies have observed much higher bioaccessibility for 375 specific PA in whole wheat breads. For example, Dall'Asta, et al. (2016) 74 found a 13.1% FA 376 bioaccessibility in whole grain bread, but this may be due to differences in the methods used, with this latter 377 study using a static digestion model. Variations in bioaccessibility in whole wheat breads may also differ due 378 to the type of whole wheat or whole grain bread used, as the former two studies produced breads from flour 379 at lab level, while the latter used a commercial whole grain bread which may have been exposed to different, 380 perhaps greater, degrees of processing. Furthermore, there seem to be no differences in bioaccessibility for 381 different types of PA. For example, FA appears to have lower percentage bioaccessibility compared to CA 382 and SA, regardless of the analytical method 74, 83 . This may be due to different distributions of phenolic 383 compounds in the free, conjugated, and bound forms. 384 Szawara-Nowak and colleagues (2016) 75 , following in vitro digestion of white wheat bread, found a soluble 385 fraction of these compounds quite comparable to the content in dark wheat bread (∼9 mg rutin equivalent/g 386 dry weight). They reported, for both white and dark bread, an exceptionally large increase in rutin post 387 versus pre-digestion (∼20 and ∼9 fold, respectively), which is much greater compared to any other study.
Similar unexpected increases following digestion were also found with increasing substitution of buckwheat 389 flour (both white and roasted) in white and dark breads 75 . Authors hypothesized this may be due to an 390 increase in the extractability of phenolic compounds resulting from the parameters set in their in vitro 391 digestion, including pH, temperature, incubation times, and extraction solvent. 392
As reported in Table 1 , a strategy to increase PA content in bread includes modifications to the raw 393 materials. The use of different types of cereals or pseudocereals, or a mixture of them, is a strategy to 394 increase PA content which has become increasingly common 85 . In the above-mentioned study, Angioloni 395
and Collar (2011) 72 assessed the differences in TPC in breads made with oat, rye, buckwheat and wheat 396 flours. Among the four breads made with 100% of one single type of flour, the TPC (measured by Folin-397
Ciocalteau method) in the initial bread was highest in buckwheat (808 mg GAE/kg), followed by wheat (685 398 mg GAE/kg), oat (643 mg GAE/kg) and rye (536 mg GAE/kg). Following in vitro digestion, although the 399 bioaccessibility of TPC was greatest in the rye bread (62%), the net PA content was greatest in the 100% 400 wheat bread (401 mg GAE/kg) with 58% bioaccessibility, followed by buckwheat (366 mg GAE/kg; 45%), 401 rye (334 mg GAE/kg; 62%) and then oat (264 mg GAE/kg; 41%). The lower bioaccessibility in the 402 buckwheat and oat breads may be due to their substantially greater fibre and protein contents in the 403 respective flours (13.8% and 17.4%, and 18.9% and 21.5%, respectively) compared to the white wheat and 404 rye breads (2.2% and 12.6%, and 14.6% and 9.6%, respectively). The higher fibre and protein content may 405 partially prevent the digestive enzymes to free bound PAs, thus limiting their bioaccessibility. The same 406 study also assessed blends of flours, specifically the multigrain bread "blend 15%" (oat:rye:buckwheat:wheat 407 TPC bioaccessibility, with the highest value (80%) reached with the 15% blend. However, the net TPC was 411 comparable between the 3 blends (472, 549, 504mg GAE/kg corresponding to the 15, 20, 25% blends), and 412 was actually greater than any of the 100% breads (401, 366, 334 and 264 mg GAE/kg, for wheat, buckwheat, 413 rye and oat breads, respectively). Therefore, there may be some influential effect on PA bioaccessibility 414 resulting from mixed grains, regardless of the actual quantities of each individual type. Comparing the 100%initial TPC content of the 100% wheat flour bread was higher (685 vs. 592mg GAE/kg TPC), yet the final 417 bread TPC is higher in the 15% blend (472 vs. 401mg GAE/kg). 418
In another study by the same authors, a 40% barley bread (made by replacing 40% wheat flour with barley 419 flour) showed no difference in net TPC (597 vs. 598 mg/100g, respectively) and a much lower % 420 bioaccessibility (60% vs. 84%, respectively, although the difference in TPC in the flour was higher (1003 421 mg/100g vs. 713 mg/100g) 78 . Perhaps the specific barley flour used, commercial barley flour, had low 422 bioaccessibility due to greater fibre content (4.01 vs. 1.15 g/100g, in the respective breads). When the type of 423 barley flour was changed to a high β-glucan barley flour, the percentage bioaccessibility was still lower 424 compared to the bread made from refined common wheat flour (42% vs. ~84%, respectively), again likely 425 due to the higher fibre content (11.91 vs. 1.15 g/100g in the respective breads). However, the net TPC was 426 much greater in the high β-glucan barley bread compared to the 100% white wheat bread (857 vs. 598 427 mg/100g, respectively) because the TPC in the raw flour was ~3-fold higher (2197 vs. 713 mg/100g, 428 respectively). Beta-glucan is a soluble, viscous-type fibre, which may therefore contribute to the low PA 429 bioaccessibility since β-glucans can produce viscous gels able to entrap nutrients and phytochemicals, 430 including phenolics, as previously hypothesized 72 . This may also explain part of the particularly lower 431 bioaccessibility in the oat bread found in the study discussed above 72 , since oats are also a rich source of β-432 glucan soluble fibre. Overall, these studies demonstrate that the types of grain flour used in blends may be 433 influential on PA bioaccessibility. 434
Another way to increase PA content in breads by modifications of raw materials includes the addition of 435 selected fractions from the original grain. One of the most commonly used fractions is the cereal bran, as it is 436 a recognized source of phenolics, including PAs. Mateo Anson et al. (2009b) 84 compared a wholemeal bread 437 to a wholemeal bread added with native wheat bran. Although they found the same FA bioaccessibility in 438 both breads (1.1%), the net FA content in the wholemeal bread plus bran was greater, since the bread plus 439 bran had a greater initial content of FA (1300 µg/g vs. 800 µg/g). The potential reason why the FA 440 bioaccessibility was the same between the breads is because the bioaccessibility of FA is mainly associated 441 with the amount of free FA present in breads, and the FA in the bran is mostly bound. Mateo Anson et al. 442 (2009b) 84 demonstrated a strong correlation between the amount of free FA and bioaccessibility among five 443 compared wheat bread made with bioprocessed rye bran to the same bread made with native rye bran and 445 found that FA bioaccessibility was significantly greater in the bread with the bioprocessed rye bran (88% vs. 446 51%, respectively). This was also reflected in the bioaccessibility of total PAs (89% vs. 53%, respectively). 447
The bioaccessibility was not directly calculated in this study. However, by calculating it as the difference 448 between polyphenol content in the original sample and the residue of the enzymatic digestion 86 , percentage 449 bioaccessibility of PAs was inferred. 450
In addition to the use of bran, bread can be enriched with the polyphenol-rich aleurone fraction, as was 451 another where the wheat bran had been both fermented and enzymatically treated with xylanase, β-488 glucanase, α-amylase, cellulase and ferulic acid esterase 84 . All three breads had the same initial content of 489 FA, CA and SA. However, after a dynamic digestion method was applied, the bioaccessibility of FA was 490 twice as high in the bread with fermented wheat bran and 5-fold higher in the bread with fermented and 491 enzymatically treated wheat bran, compared to the bread with native wheat bran. A slightly smaller but 492 similar trend was observed for CA and SA. The great increase in bioaccessibility in the bread with 493 bioprocessed bran may be due to the hydrolysis of different wheat fibre polymers resulting from to the 494 hydrolytic enzymes, which may lead to a structural breakdown of bran cell walls. 495
Mandak and Nystrom (2013)
77 also evaluated the effect of enzymatic treatment, and assessed the 496 bioaccessibility of steryl ferulates, which are phytosterols that can be esterified to FA, in breads made with 497 two types of wheat flour, either with or without the use of the enzymes cellulose or xylanase, alone or in 498 combination. The bioaccessibility of steryl ferulate (calculated as the percentage in the supernatant compared 499 to the total extractable amount) was generally very low (0.01-0.25%), although when both enzymes wereused, bioaccessibility increased from 0.01 to 0.25% in wholegrain breads, but only from 0.09 to 0.10% in 501 baking flour breads. The differences in effect of enzymatic treatment seen in this study versus the study by 502
Mateo Anson et al. (2009b)
84 may be: i) the specificity in the phenolic compounds assessed (steryl ferulates 503 vs. PAs); ii) the specific enzymes used and the number and combination of them (xylanase and cellulase vs. 504 β-glucanase, xylanase, α-amylase and ferulic acid esterase); iii) the method of bread preparation (direct 505 incorporation of the enzymes to the flour vs. preliminary bioprocessing of bran); and iv) the digestion 506 method employed (static vs. dynamic). 507
As previously mentioned, Koistinen et al. (2017) 76 recently investigated the bioaccessibility of phenolic 508 compounds in a bioprocessed (by enzymatic treatment and fermentation) rye bran added to wheat bread, and 509 found a stunning 88% bioaccessibility of FAs. Bioaccessibility was therefore much higher than that of the 510 two previous studies, possibly because a considerable amount of phenolic bound compounds became 511 available due to the addition of enzymes and the activation of endogenous enzymes resulting from 512
fermentation. 513
The bioaccessibility of PAs in bread was also increased when wheat bran was dry-fractionated. Hemery et al. 514 (2010) 83 analysed free, conjugated, bound and total FA, SA and CA in bread made following bran ultra-fine 515 grinding and bran electrostatic separation. They found that the finer the bran particles in bran-rich breads, the 516 more bioaccessible the PAs (following Tiny-TIM digestion), with a very strong correlation between FA 517 bioaccessibility and the proportion of small particles (10-20 µm diameter). The bioaccessibility of SA was 518 generally much higher than that of CA or FA (26-33% versus 6-13% and 2.5-3.4%), likely because SA is 519 mainly present in the conjugated form and within the aleurone grains 88 . Furthermore, although the breaking 520 of covalent bonds during extensive milling contributes to increased bioaccessibility 89 , the particle size of the 521 samples seems to play a role in determining the bioaccessibility of phenolic compounds, possibly through an 522 improvement of the extractability resulting from micronization 90 . The described study also found SA 523 bioaccessibility was highly correlated to the proportion of small particles (<10um diameter), and the authors 524 furthermore evaluated also bread made with positive and negative fractions obtained by electrostatic 525 separation of bran, after the highest level of grinding (cryo-ultrafine), and demonstrated these to have the 526 highest amount of bioaccessible PAs. The charge of these particles was influenced by the type of cell walls 527 pericarp (outer cell wall), rich in highly branched and cross-linked arabinoxylans (negatively charged) and 529 particles rich in β-glucan, FA and CA from aleurone cell walls (positively charged) 91 . These results provide 530 insights for the improvement of electrostatic separation processes able to select specific fractions rich in free 531 and conjugated PAs 40 . 532
Overall, the studies investigating the bioaccessibility of phenolic compounds in bread suggest alterations, 533 such as the incorporation of polyphenol-rich raw materials and, especially, the application of different bio-534 processing techniques represent promising strategies to increase the amount of bioaccessible phenolic 535 compounds in bread. The significant variations among the in vitro methods used impede a proper 536 comparison of the results across studies and make the possibility to deduce general findings very difficult. To 537 circumvent this, Minekus et al. 2014 92 recently published an international consensus paper aimed at 538 introducing a standardised in vitro digestion method to analyse food, providing recommendations for every 539 step of digestion. Adoption of this standardized method will assist in comparison of multiple study results in 540 the future, allowing for clearer conclusions to be drawn. 541
542
BIOAVAILABILITY OF PHENOLIC COMPOUNDS IN BREAD: in vivo studies 543
Determining the content of bioactive compounds in food products or their sole bioaccessibility in vitro is not 544 sufficient per se to predict their potential health effects in vivo. Therefore, in vivo studies are important to 545 determine the bioavailability of PAs in order to understand the amount of PA actually absorbed post-546 ingestion, becoming therefore available to elicit health effects. 547
A review of the literature identified 5 studies investigating the bioavailability of PAs from standard versus 548 bioprocessed bread (Table 3 ). The most common methodology used in vivo to assess phenolic bioavailability 549 is represented by acute studies, where subjects are provided a single-dose of the test food and biological 550 samples (e.g. blood, urine) are collected pre-and post-consumption. The changes, therefore, reflect the 551 ability to absorb polyphenols from a complex food matrix 93 . Three out of the five identified studies were 552 single-dose acute studies, with 2 evaluating the bioavailability of phenolics in bread in urine and plasma 49, 94 553 and 1 in urine alone 95 . 554 performed an enzymatic hydrolysis of the urinary sample by using a mixture of β-glucuronidase and 559 sulfatase from Helix pomatia. This reaction allows to cleave the glucuronic and sulfonic moieties of the 560 phase II metabolites and to detect the only aglycones, to which the bioavailability is accounted for. 561
As discussed, raw materials as well as bioprocessing techniques in bread-making play important roles in the 562 bioavailability of phenolic compounds in breads. Product innovation in these acute studies was based on 563 three main strategies: i) the addition of aleurone fraction to commercial wheat breads 94 ; ii) bioprocessing of 564 wheat bran added to a whole grain bread 49 ; and iii) the use of rye bread and rye bran 95 . 565
All 3 acute studies evaluated the urinary bioavailability of FA. Bresciani et al. (2016) 94 fed healthy 566 volunteers, on three separate days, a wholegrain bread and a 6% w/w aleurone-enriched bread at two 567 different servings of 94 g and 190 g, containing 43 mg and 87 mg total FA, respectively. Results showed a 568 significant 2-fold higher FA bioavailability (as the sum of FA metabolites ferulic acid-4'-O-sulfate, 569 dihydroferulic acid-4'-O-sulfate, and dihydroferulic acid-O-glucuronide) in urine of volunteers fed with the 570 single portion of the aleurone-enriched bread compared to wholegrain bread and to the double portion of 571 aleurone-enriched bread. Intriguingly, no significant difference was found in urinary FA bioavailability 572 between the double portion of aleurone-enriched and wholegrain breads (~5% and ~4%, respectively). The 573 authors commented that the higher bioavailability derived from the lower ferulic consumption in the single 574 compared to double portion of aleurone-enriched bread may be due by a reduction in the capacity to 575 metabolize and absorb PAs as intake increases. 576
Mateo Anson et al. (2011)
49 demonstrated similar results when breads were standardized to contain the same 577 initial total PA amount. Specifically, they found 10% FA bioavailability in the bread with bioprocessed bran 578 compared to 4% in the whole wheat control bread with native bran (21.34 mg/24h vs. 9.89 mg/24h FA in 579 urine, p < 0.05). Furthermore, Lappi et al. (2013) 95 found a 2.5-fold greater urinary FA excretion after 580 consumption of whole wheat bread with bioprocessed rye bran compared to the same whole wheat bread 581 with native rye bran and with control wheat. For a thorough comprehension of the results of this study, it is 582 important to consider the initial amount of FA in the fed bread. Indeed, the control wheat bread in this studycompared to both the rye or the bioprocessed rye brans. Thus, the total FA urinary excretion was lower (0.27 585 mg/d in control whole wheat bread vs. 1.66 mg/d from bioprocessed rye bran bread vs. 0.45 mg/d in native 586 rye bran bread, corresponding to 3.2%, 1% and 0.4% FA bioavailability, respectively). Therefore, although 587 the percentage bioavailability may be higher, if the initial intake is lower, the total amount absorbed may 588 nevertheless be lower. 589
The application of bioprocessing techniques to breads, similarly, elicited increased bioavailability for SA and 590
other PAs. The study by Mateo Anson and colleagues (2011) 49 found that the amount of SA in 24-hour urine 591 corresponded to a 15% and 7% bioavailability in bioprocessed bran and control breads, respectively. 592
However, the bioavailability for CA equalled 2% for both the bioprocessed and control breads. Lappi et al. 593 (2013) 95 showed a 0.6% SA bioavailability for the bioprocessed bread compared to a 2.8% for white wheat 594 bread, and generally all three breads were characterised by a ~4-fold lower SA bioavailability compared to 595 the white wheat bread. In spite of this, the bioprocessed bread showed the highest excreted SA net amount 596 hour urine excretion and demonstrated 160% and 104% bioavailability in the bioprocessed and control 599 breads, respectively, and both had similar initial concentrations in breads (0.018 mg/g and 0.017 mg/g, 600 respectively), thus the bioprocessed bran bread resulted in greater vanillic acid absorption. Authors did not 601 provide a possible explanation for such high recoveries, which could be at least partially attributable to an 602 insufficient initial extraction of phenolics from the bread. 603
Two studies also evaluated blood concentrations of phenolic compounds after bread consumption 49, 94 and 604 both demonstrated increased hippuric and hydroxyhippuric acid plasma levels after bread consumption. 605
However, being degradation products from several different metabolic pathways, these two catabolites 606 cannot be considered uniquely associated to polyphenol metabolism 22 . The second most concentrated 607 polyphenol compound in plasma was FA, together with its main phase II conjugates. Bresciani et al. ) 97 similarly compared the consumption of 4-5 slices/d of rye bread with wheat bread for 4 weeks in 619 a randomized, crossover design with a 4-week washout in 43 healthy volunteers (Table 3) . Although it was 620 not possible to calculate the bioavailability of phenolic compounds in the breads because measurements 621 would have had to include phenolics found in foods consumed during the rest of the daily diet, 622 measurements of phenolic metabolites in blood (plasma) and urine samples were compared after 623 consumption of the different bread interventions. Moreover, in the study by Harder et al. (2004) 96 , in 624 addition to rye bread, the authors also included rye-enriched muffins and crisp bread products, thus making 625 the FA amount found in biological samples not originating solely from bread. These authors measured FA 626 concentration in 48-hour urine collections and found urinary FA excretion was ~2 mg/24hour for the habitual 627 diet (i.e. at baseline) and at the end of 6-weeks after the incorporation of white wheat bread (Vitacell ® ). 628
However, at the end of 6-weeks of the intervention with rye bran-enriched bread products, FA excretion was 629 2.5-fold higher (p< 0.05) compared with both the control wheat bread intervention (40.2% higher, p= 0.001) 630 and the baseline diet (39.8% higher, p= 0.002). Considering the 10.2 mg FA/day intake during the rye bran 631 intervention, the study demonstrated a recovery of 28% of FA metabolites. 632
Juntunen et al. (2000) 97 considered the plant lignans, secoisolariciresinol (SECO) and matairesinol (MAT), 633 which are found in large quantities in rye cereal-based products and bio-transformed by gut microbiota into 634 enterodiol and enterolactone (ENL), respectively, and the latter finally oxidized to ENL. After a 4-week 635 dietary intervention on either wheat or rye bread consumption, total ENL excretion in 24-hour urine samples 636 almost doubled after rye bread consumption (6.8 µmol/day for men and 7.8 µmol/day for women) compared 637 to the period with wheat control bread (4.0 µmol/day for men and 3.7 µmol/day for women). However, 24-638 hour urine ENL concentration at the end of the rye intervention was not significantly different from theurinary excretion, which is interesting considering the intake of rye bread was more than double during the 641 rye bread intervention compared to the habitual diet. Additionally, no difference in serum ENL 642 concentrations between pre-and post-rye intervention was observed and again, there was no correlation 643 between rye intake and serum ENL concentration. It is possible that a plateau of ENL is physiologically 644 reached independently from the intake of rye bread. 645
CONCLUSIONS AND REMARKS 646
Phenolic compounds are recognized for several beneficial effects on human health. These effects depend not 647 only on their content in food products but also on their ability to be absorbed and become available within 648 the human body. For this reason, in vitro and in vivo studies have been performed with the aim of 649 investigating the bioaccessibility and bioavailability of phenolic compounds, respectively, suggesting that the 650 use of specific raw materials (e.g. cereals/pseudocereals as alternatives to wheat, or specific cereal fractions) 651 or of pre-processing techniques might represent valuable strategies for enhancing the phenolic content in the 652 raw materials and for increasing the amount of bioaccessible and bioavailable compounds. 653
Unequivocal conclusions could not be drawn at present, as the available studies widely differ for fed 654 amounts of phenolic compounds and, more importantly, for the methodologies applied. This highlights a 655 great need for standardization of methodologies used in in vitro studies in order to be able to compare results 656 and draw conclusions on the potential usefulness of the application of innovative techniques to improve 657 phenolic bioaccessibility. The few in vivo studies identified also highlight the need for further research to be 658 carried out in this area to assess the effectiveness of the application of new strategies in the bread-making 659 process on phenolic bioavailability. With the ultimate goal of eliciting health benefits, intervention trials will 660 be required to assess if strategies that demonstrate effectiveness at increasing phenolics bioavailability 661 translate then to improvements in health outcomes in humans. CA, p-coumaric acid; CAF: caffeic acid; FA, ferulic acid; GAE, gallic acid equivalents; PA, phenolic acid; SA, sinapic acid; TPC, total phenolic acid content; dw: dry weight.
ⱡ as measured in the bread pre-digestion, unless otherwise indicated * % of bioaccessibility was calculated as the percentage of phenolic compounds in the residue after in vitro digestion compared to the initial amount of total PAs/TPC in bread -Men: 25.6 nM; -Women: 39.7 nM. -Significant higher serum ENL concentrations at the end of rye-brad intervention compared to wheat bread one (+51.2% for men, +62.7% for woman, p <0.05).
-Not significant differences in serum ENL concentration at the end of rye-and wheat-brad compared to baseline.
-Urinary ENL 24 h-excretion -Wheat bread: -Men: 4.0 µmol; -Women: 3.7 µmol. -Rye bread:
-Men: 6.8 µmol; -Women: 7.8 µmol.
-Significantly higher (p< 0.05) ENL 24 h-excretion in rye-compared to wheat-bread periods in both men and women. -No correlation between urine ENL and rye bread intake.
AUC 0-t : area under the curve; C max : maximum plasma concentration; CA, p-coumaric acid; ENL: enterolactones; FA, ferulic acid; SA, sinapic acid; VA, vanillic acid.
* % of bioavailability was calculated as % ratio between the amount of the compound in the biological fluid on the amount of the ingested compound.
